VetASSIST的协议:一种随机对照试验,用于评估多病症退伍军人的虚拟同行健康指导
Kristen E Gray1, Jennifer L Williams2, Andrades Rivera-Remines2
1VA Puget Sound Health Care System, Seattle Division, Health Systems Research, 1660 South Columbian Way (S-152), Seattle, WA 98108, USA; University of Washington, School of Public Health, Department of Health Systems and Population Health, 3980 15(th) Ave NE, Fourth Floor, Box 351621, Seattle, WA 98195, USA.
Contemporary clinical trials
|August 16, 2025
概括
一个由退伍军人领导的健康指导计划,VetASSIST,旨在改善多种慢性疾病患者的生活质量. 这项随机试验将确定同行辅导是否有效地支持该人群的自我管理和福祉.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 超过一半的退伍军人事务部 (VA) 患者患有多病症,定义为两个或两个以上同时出现的慢性疾病.
- 多种疾病严重损害与健康相关的生活质量,增加残疾和死亡率,并导致高医疗保健成本.
- 有效的自我管理策略对于多病症患者至关重要,但也带来了独特的挑战.
研究的目的:
- 评估VetASSIST的有效性,这是一个由退伍军人领导的同步视频同行健康指导干预.
- 确定VetASSIST是否可以帮助多病症患者克服自我管理障碍,提高与健康相关的生活质量.
- 评估同行健康指导对与身体和心理健康相关的生活质量和医疗保健利用的影响.
主要方法:
- 一项随机对照试验,涉及294名退伍军人,在三个或更多的身体系统中至少有三种慢性疾病.
- 参与者被随机分配1:1到通常的护理或通常的护理加上退伍军人同行健康指导 (VetASSIST).
- 干预组在一年内接受了20次视频访问,包括健康教育,自我管理支持,资源链接和受过训练的退伍军人同行的社会支持.
主要成果:
- 主要结局是身体健康相关生活质量的12个月变化,通过SF-12测量.
- 二次结果包括12个月的心理健康相关生活质量变化 (SF-12) 和医疗保健利用率.
- 这项试验旨在提供关于同行健康指导对多病症有效性的可靠数据.
结论:
- 这项试验将确定同行健康指导计划是否可以有效地促进多病症患者的健康和福祉.
- 积极的发现可以支持在VA和其他医疗保健系统中实施VetASSIST计划.
- 该研究旨在提供一个可扩展和有效的模型,以支持具有复杂健康需求的高风险患者.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Clinical Trials
8.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.3K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


